Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

XMU-MP-1

XMU-MP-1
XMU-MP-1 is an inhibitor of the pro-apoptotic, sterile 20-like kinases MST1 and 2.
Catalog No. T4212Cas No. 2061980-01-4
Select Batch
Purity:99.68%
Contact us for more batch information
Resource Download

XMU-MP-1

Catalog No. T4212Cas No. 2061980-01-4
XMU-MP-1 is an inhibitor of the pro-apoptotic, sterile 20-like kinases MST1 and 2.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
1 mg$48In Stock
2 mg$72In Stock
5 mg$98In Stock
10 mg$155In Stock
25 mg$322In Stock
50 mg$538In Stock
100 mg$778In Stock
1 mL x 10 mM (in DMSO)$96In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "XMU-MP-1"

Product Introduction

Bioactivity
Description
XMU-MP-1 is an inhibitor of the pro-apoptotic, sterile 20-like kinases MST1 and 2.
Targets&IC50
MST2:38.1 nM, MST1:71.1 nM
In vitro
XMU-MP-1 effectively reduces the phosphorylation of MOB1, LATS1/2, and YAP in HepG2 cells in a concentration-dependent manner, with effective doses ranging from 0.1 to 10 μM. It also inhibits MOB1 phosphorylation induced by hydrogen peroxide and prevents MST1/2 autophosphorylation across various cell lines, including mouse macrophage-like cells, human osteosarcoma, and human colorectal adenocarcinoma cells. By blocking MST1/2 kinase activities, XMU-MP-1 activates the downstream effector, Yes-associated protein (YAP), thereby promoting cell growth. Its action potently and reversibly suppresses the activities of MST1/2 kinases, enhancing YAP activation in cells.
In vivo
XMU-MP-1 demonstrates excellent in vivo pharmacokinetics and enhances intestinal repair, as well as liver repair and regeneration, in both acute and chronic liver injury mouse models at doses of 1 to 3 mg/kg via intraperitoneal injection. In the Fah-deficient mouse model, XMU-MP-1 treatment significantly increased the repopulation rate of human hepatocytes compared to the vehicle-treated control, suggesting it may facilitate human liver regeneration. Therefore, pharmacological modulation of [MST1/2] kinase activities offers a novel method to enhance tissue repair and regeneration, with XMU-MP-1 as the initial lead for developing targeted regenerative therapeutics.
Kinase Assay
XMU-MP-1 is dissolved in DMSO (stock concentration, 10 mM). For the in vitro kinase inhibition assays, recombinant GST-tagged MOB1a and various forms of recombinant His-tagged full-length MST1 or MST2 kinase are expressed and purified from Escherichia coli. The assays are performed with the various doses of XMU-MP-1 in the kinase assay buffer for 30 min at 30°C[1].
Chemical Properties
Molecular Weight416.48
FormulaC17H16N6O3S2
Cas No.2061980-01-4
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 12.5 mg/mL (30.01 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.4011 mL12.0054 mL24.0108 mL120.0538 mL
5 mM0.4802 mL2.4011 mL4.8022 mL24.0108 mL
10 mM0.2401 mL1.2005 mL2.4011 mL12.0054 mL
20 mM0.1201 mL0.6003 mL1.2005 mL6.0027 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy XMU-MP-1 | purchase XMU-MP-1 | XMU-MP-1 cost | order XMU-MP-1 | XMU-MP-1 chemical structure | XMU-MP-1 in vivo | XMU-MP-1 in vitro | XMU-MP-1 formula | XMU-MP-1 molecular weight